7.76
price down icon5.37%   -0.44
after-market アフターアワーズ: 8.21 0.45 +5.80%
loading
前日終値:
$8.20
開ける:
$9.04
24時間の取引高:
26,199
Relative Volume:
0.58
時価総額:
$50.57M
収益:
-
当期純損益:
$-31.48M
株価収益率:
-7.4615
EPS:
-1.04
ネットキャッシュフロー:
$-28.71M
1週間 パフォーマンス:
+22.78%
1か月 パフォーマンス:
-14.73%
6か月 パフォーマンス:
+38.82%
1年 パフォーマンス:
-55.42%
1日の値動き範囲:
Value
$7.61
$9.04
1週間の範囲:
Value
$7.01
$9.0775
52週間の値動き範囲:
Value
$4.11
$28.68

Forte Biosciences Inc Stock (FBRX) Company Profile

Name
名前
Forte Biosciences Inc
Name
セクター
Healthcare (1164)
Name
電話
(310) 618-6994
Name
住所
3060 PEGASUS PARK DRIVE, DALLAS, CA
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
FBRX's Discussions on Twitter

FBRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
FBRX
Forte Biosciences Inc
7.76 50.57M 0 -31.48M -28.71M -1.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-21 開始されました TD Cowen Buy
2024-04-08 アップグレード Ladenburg Thalmann Neutral → Buy
2021-09-20 アップグレード Chardan Capital Markets Sell → Buy
2021-09-03 ダウングレード B. Riley Securities Buy → Neutral
2021-09-03 ダウングレード Chardan Capital Markets Buy → Sell
2021-09-03 ダウングレード Ladenburg Thalmann Buy → Neutral
2021-09-03 ダウングレード Truist Buy → Hold
2021-05-14 開始されました B. Riley Securities Buy
2021-03-26 開始されました Citigroup Buy
2020-08-28 アップグレード Chardan Capital Markets Neutral → Buy
2020-08-25 開始されました Truist Buy
すべてを表示

Forte Biosciences Inc (FBRX) 最新ニュース

pulisher
09:00 AM

Forte's Celiac Treatment Shows Promise: Zero Dropouts and $58.4M War Chest - Stock Titan

09:00 AM
pulisher
08:59 AM

Forte Biosciences, Inc. Announces Results and Provides Clinical Update - Bluefield Daily Telegraph

08:59 AM
pulisher
Mar 28, 2025

Forte Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Forte Biosciences Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Forte Biosciences, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Forte Biosciences Inc. (FBRX) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 27, 2025

(FBRX) Long Term Investment Analysis - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 25, 2025
pulisher
Mar 15, 2025

FORTE BIOSCIENCES Earnings Preview: Recent $FBRX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025
pulisher
Mar 15, 2025

Forte Biosciences (FBRX) to Release Earnings on Monday - The AM Reporter

Mar 15, 2025
pulisher
Mar 14, 2025

Forte Biosciences Inc expected to post a loss of $3.27 a shareEarnings Preview - TradingView

Mar 14, 2025
pulisher
Mar 14, 2025

Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Large Drop in Short Interest - Defense World

Mar 14, 2025
pulisher
Mar 10, 2025

Forte Biosciences (FBRX) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 10, 2025
pulisher
Mar 06, 2025

Traders Purchase High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

Mar 06, 2025
pulisher
Feb 28, 2025

Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update - MarketBeat

Feb 28, 2025
pulisher
Feb 25, 2025

Forte Biosciences Stock Down 20% But Insiders Still In US$92k Profit - Simply Wall St

Feb 25, 2025
pulisher
Feb 24, 2025

Pre-market Movers: ISPC, TH, IVVD, TOVX... - RTTNews

Feb 24, 2025
pulisher
Feb 23, 2025

(FBRX) On The My Stocks Page - news.stocktradersdaily.com

Feb 23, 2025
pulisher
Feb 23, 2025

Stock Traders Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat

Feb 23, 2025
pulisher
Feb 20, 2025

Evelo Biosciences Target of Unusually Large Options Trading (NASDAQ:EVLO) - Defense World

Feb 20, 2025
pulisher
Feb 19, 2025

One Forte Biosciences Insider Raised Stake By 273% In Previous Year - Yahoo Finance

Feb 19, 2025
pulisher
Feb 14, 2025

Best Stocks Under $20 Right Now - Benzinga

Feb 14, 2025
pulisher
Feb 12, 2025

Where are the Opportunities in (FBRX) - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 09, 2025

Stock Traders Buy High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat

Feb 09, 2025
pulisher
Feb 06, 2025

Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World

Feb 06, 2025
pulisher
Feb 03, 2025

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings -February 03, 2025 at 09:03 am EST - Marketscreener.com

Feb 03, 2025
pulisher
Feb 03, 2025

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - Business Wire

Feb 03, 2025
pulisher
Feb 01, 2025

(FBRX) Proactive Strategies - Stock Traders Daily

Feb 01, 2025
pulisher
Jan 30, 2025

CSG Forte Wins TSG Real Transaction Metrics Awards for Second Consecutive Year - Yahoo Finance

Jan 30, 2025
pulisher
Jan 25, 2025

Forte Biosciences expands equity incentive plan By Investing.com - Investing.com Australia

Jan 25, 2025
pulisher
Jan 25, 2025

TD Cowen initiates Forte Biosciences stock with Buy rating - MSN

Jan 25, 2025
pulisher
Jan 24, 2025

Forte Biosciences expands equity incentive plan - MSN

Jan 24, 2025
pulisher
Jan 23, 2025

Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

Jan 23, 2025
pulisher
Jan 23, 2025

Meiwu Technology (NYSE:WNW) Stock Price Down 13.2% – Here’s Why - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

Forte Biosciences (NASDAQ:FBRX) Coverage Initiated by Analysts at TD Cowen - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

TD Cowen initiates Forte Biosciences stock with Buy rating By Investing.com - Investing.com Australia

Jan 21, 2025
pulisher
Jan 21, 2025

Atopic Dermatitis Drugs Market Trends Analysis Report - GlobeNewswire

Jan 21, 2025
pulisher
Jan 11, 2025

(FBRX) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Jan 11, 2025
pulisher
Jan 09, 2025

Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX) - Defense World

Jan 09, 2025
pulisher
Jan 06, 2025

Forte Biosciences (FBRX) Is a Great Choice for 'Trend' Investors, Here's Why - MSN

Jan 06, 2025
pulisher
Dec 31, 2024

(FBRX) Technical Data - Stock Traders Daily

Dec 31, 2024
pulisher
Dec 26, 2024

Investors Purchase Large Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO) - Defense World

Dec 26, 2024
pulisher
Dec 26, 2024

Investors Buy High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

Dec 26, 2024
pulisher
Dec 20, 2024

100 cell and gene therapy leaders to watch in 2025 - Drug Discovery & Development

Dec 20, 2024
pulisher
Dec 16, 2024

Why Forte Biosciences (FBRX) Stock Is Trading Lower - Benzinga

Dec 16, 2024
pulisher
Dec 13, 2024

CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Up 8,233.3% in November - Defense World

Dec 13, 2024
pulisher
Dec 13, 2024

Traders Buy Large Volume of Call Options on Quantum-Si (NASDAQ:QSI) - Defense World

Dec 13, 2024
pulisher
Dec 12, 2024

Invea Therapeutics Strengthens Leadership with Appointment of Dr. Stephen Doberstein, Veteran Biotech Executive, to Its Board of Directors - The Manila Times

Dec 12, 2024
pulisher
Dec 10, 2024

Trading (FBRX) With Integrated Risk Controls - Stock Traders Daily

Dec 10, 2024
pulisher
Dec 05, 2024

FBRX Stock Soars to 52-Week High, Reaching $24.46 By Investing.com - Investing.com Nigeria

Dec 05, 2024
pulisher
Dec 05, 2024

Forte Biosciences’ $53 Million Equity Financing - Global Legal Chronicle

Dec 05, 2024

Forte Biosciences Inc (FBRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
大文字化:     |  ボリューム (24 時間):